Arterial thrombosis associated with adjuvant chemotherapy for breast cancer: A case report

Journal of the American Academy of Nurse Practitioners

Volumn 22, Issue 3, 2010, Pages 140-143

  Bourdeanu, Laura ^a   Luu, Thehang ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast disease; Cancer; Chemotherapy; Collaboration; Nurse practitioners; Oncology; Thrombotic disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CASE REPORT; CHEMICALLY INDUCED DISORDER; EMBOLECTOMY; FEMALE; HUMAN; LUNG CARCINOMA; MIDDLE AGED; NURSE PRACTITIONER; NURSING; RISK FACTOR; THROMBOEMBOLISM;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; ASPIRIN; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; EMBOLECTOMY; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; NURSE PRACTITIONERS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; THROMBOEMBOLISM;

EID: 77950605246     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00486.x     Document Type: Article

References (26)

1. Anderson R J, Hobson R W I, Padberg F T J. Penetrating extremity trauma: Identification of patients at high-risk requiring arteriography. Journal of Vascular Surgery 1990, 11:544-548.
2. Bauer K. The thrombophilias: Well defined risk factors with uncertain therapeutic implications. Annals of Internal Medicine 2001, 135:367-373.
3. Brose K M J, Lee A Y Y. Cancer-associated thrombosis: Prevention and treatment. Current Oncology 2008, 15(suppl. 1):S58-S67.
4. Cambria R P, Abbott W M. Acute arterial thrombosis of the lower extremity. Its natural history contrasted with arterial embolism. Archives of Surgery 1984, 119:784-787.
5. Doll D C, Ringernberg Q S, Yarbro J W. Vascular toxicity associated with antineoplastic agents. Journal of Clinical Oncology 1986, 4:1405-1417.
6. Donati M B. Cancer and thrombosis: From phlegmasia alba dolens to transgenic mice. Haemostasis 1995, 14:442-449.
7. Falanga A, Donati M B. Pathogenesis of thrombosis in patients with malignancies. International Journal of Hematology 2001, 73:137-144.
8. Goodnough L T, Saito H, Manni A, Jones P K, Pearson O H. Increased incidence of thromboembolism in stage IV breast cancer treated with a five-drug chemotherapy regimen: A study of 159 patients. Cancer 1984, 54:1264-1268.
9. Group A T. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. The Lancet 2002, 359:2131-2139.
10. Jackson M R, Clagett G P. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 1998, 114:666S.
11. Javid M, Magee T R, Galland R B. Arterial thrombosis associated with malignant disease. European Journal of Endovascular Surgery 2008, 35:84-87.
12. Kannel W B, Wolf P A, Castelli W P, D'Agostino R B. Fibrinogen and risk of cardiovascular disease, the Framingham study. Journal of American Medical Association 1987, 258:1183-1186.
13. Khamashta M A, Cuadrado M J, Loizou S. The management of thrombosis in the antiphospholipid antibody syndrome. New England Journal of Medicine 1995, 332:993-997.
14. Khorana A A, Liebman H A, White R H, Wun T, Lyman G H. The risk of venous thromboembolism in patients with cancer. American Society of Clinical Oncology educational book, 2008 2008, 240-248. In, (pp.
15. Levine M N, Gent M, Hirsh J, Arnold A, Goodyear M D, Hryniuk W. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. New England Journal of Medicine 1988, 7:404-407.
16. Lowe G D O. Measurement of thrombosis and its prevention. British Journal of Clinical Pharmacology 2002, 54:96-100.
17. Lowe G D O. Common risk factors for both arterial and venous thrombosis. British Journal of Haematology 2008, 140:488-495.
18. Nand S, Fisher S G, Salgia R, Fisher R. Hemostatic abnormalities in untreated cancer: Incidence, and correlation with thrombotic hemorrhagic complications. Journal of Clinical Oncology 1987, 5:1998-2003.
19. Rickels F R, Edwards R L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983, 62:14-31.
20. Roseve M H, Brewer P M. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine 1992, 117:303-308.
21. Ruiz M A, Marugan I, Estelles A, Navarro I, Espana F, Abberola V. The influence of chemotherapy in plasma coagulation and fibrinolytic systems of lung cancer patients. Cancer 1989, 63:643-648.
22. Saphner T, Tormey D C, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. Journal of Clinical Oncology 1991, 9:286-294.
23. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. American Journal of Medicine 1998, 104:332-338.
24. Skhror K. Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Seminars in Thrombosis and Hemostasis 1997, 23:349-356.
25. Wall J G, Weiss R B, Norton L, Perloff M, Rice M A, Korzun A H. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study. American Journal of Medicine 1989, 87:501-504.
26. Weiss R B, Tormey D C, Holland J F, Weinberg V E. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treatment Reports 1981, 65:677-679.